The PGIM Jennison Health Sciences Fund outperformed its index in 2025 amid a recovery in the health care sector. Read the full analysis for more details.

This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content. The placement of ...

The Philippines is recognized as Southeast Asia’s pioneer in agricultural biotechnology. It was the first in the region to establish a regulatory framework for genetically modified (GM) crops. It ...

The report found that while the U.S. leads in quantum information science research, other countries are more focused on AI ...

Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression 14-Month Follow-up Data Show Hypoimmune (HIP)-Mod ...

Forget the era of quick fixes and makeshift patches. IIT Madras is replacing the chaos of jugaad with precision science to ensure that going green is finally affordable for every Indian.

Eupraxia Pharmaceuticals Inc. ('Eupraxia” or the 'Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

Colorectal cancer is one of the cancers where, if found early, it has a 91% chance of survival for the patient. If you find ...

Partnership leverages Tenacia’s expertise in central nervous system (CNS) drug development and commercialization to ...

Shared 12-month clinical results of ongoing UP421 type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression are safe and well-tolerated, evad ...